Schonfeld Strategic Advisors LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 127 filers reported holding TG THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,431,464
-11.0%
1,367,400
+164.5%
0.09%
-19.1%
Q2 2023$12,839,622
-19.9%
516,893
-51.5%
0.11%
-28.1%
Q1 2023$16,020,803
+2049.6%
1,065,213
+1590.8%
0.15%
+2450.0%
Q4 2022$745,290
+219.9%
63,000
+60.1%
0.01%
+200.0%
Q3 2022$233,000
-87.4%
39,348
-91.0%
0.00%
-88.9%
Q2 2022$1,854,000
+51.5%
436,331
+1753.8%
0.02%
+12.5%
Q4 2020$1,224,000
-29.4%
23,537
-73.5%
0.02%
-30.4%
Q2 2020$1,734,000
+729.7%
88,958
+319.3%
0.02%
+76.9%
Q1 2020$209,000
-55.7%
21,218
-36.2%
0.01%
-62.9%
Q1 2018$472,00033,2770.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders